The Rapid COVID-19 Innova Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nose and/or throat swab from individuals who are suspected of COVID-19 by their healthcare provider.
It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. Currently, individuals infected by SARS-CoV-2 are the main source of transmission; asymptomatic carriers are also known as a source of transmission. Based on the current epidemiological information, the incubation period can last from 1 to 14 days, where the average time before symptoms occur is about 5 days. Symptoms include fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, runny nose, nausea or vomiting and diarrhea.
These rapid lateral flow tests generate accurate results, usually within 15 minutes. This Antigen test has 100% specificity, 98.98% overall accuracy.
Qualitative, visually read results in 15 minutes
No instrument required
Room temperature storage or refrigerated (2-30⁰C / 36-86⁰F)
Procedural internal control included
Sterile Swabs, Extraction Buffer and Extraction Tubes included
Dispose of used test components according to the IFU
If you require a Fit-To-Fly or Test-And-Release certificate then please consult the UK Government website to find the appropriate service provider: https://www.gov.uk/find-travel-test-provider
We do not offer certification nor activation of QR codes.